A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants

NCT07463196 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Placebo
DRUG: ACI-19764 at dose A1
DRUG: ACI-19764 at dose A2
DRUG: ACI-19764 at dose A3
DRUG: ACI-19764 at dose A4
DRUG: ACI-19764 at dose A5
DRUG: ACI-19764 at dose A6
DRUG: ACI-19764 at dose B1
DRUG: ACI-19764 at dose B2
DRUG: ACI-19764 at dose B3

Sponsor

AC Immune SA

Collaborators

ICON Clinical Research